Trial Condition(s):

Diabetes Mellitus, Type 2

Study to learn more about outcomes reported by patients suffering from type 2 diabetes using a digital data collection tool (DePRO)

Bayer Identifier:

21318

ClinicalTrials.gov Identifier:

NCT04383041

EudraCT Number:

Not Available

Study Completed

Trial Purpose

In this study researchers want to gain more information on patients who are treated with Metformin for their Type 2 Diabetes. Adult female and male patients with a prescription of a Metformin containing drug will be invited to the study in a public pharmacy after the decision for treatment with Metformin has been made by the treating physician. The pharmacist will provide interested participants access to a special phone App and participants are asked to complete via this phone App a questionnaire on their health situation with special focus on their Type 2 Diabetes. This includes questions on complications and self-care activities in relation to their diabetes, questions on quality of life and health history. There will be no extra visit to the treating doctor or a pharmacy. The study is aiming to have the questionnaire completed by 300 participants.

Inclusion Criteria
- Adult female or male patient 
- Valid prescription for a Metformin containing drug approved in Germany
- Decision to initiate treatment with Metformin was made by the treating physician as part of the  routine treatment practice
- Signed informed consent
Exclusion Criteria
- Not applicable

Trial Summary

Enrollment Goal
32
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
No Drug
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many locations

Many locations, Germany

Status
Completed
 

Trial Design